4ydk
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120== |
- | + | <StructureSection load='4ydk' size='340' side='right' caption='[[4ydk]], [[Resolution|resolution]] 2.05Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[4ydk]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YDK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YDK FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=NHE:2-[N-CYCLOHEXYLAMINO]ETHANE+SULFONIC+ACID'>NHE</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | |
- | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4ydi|4ydi]], [[4ydj|4ydj]], [[4ydl|4ydl]]</td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ydk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ydk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ydk RCSB], [http://www.ebi.ac.uk/pdbsum/4ydk PDBsum]</span></td></tr> | |
- | [ | + | </table> |
- | [[Category: Kwong, P | + | == Function == |
+ | [[http://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1]] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity). | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Kwong, P D]] | ||
[[Category: Moquin, S]] | [[Category: Moquin, S]] | ||
- | [[Category: Zhou, T]] | ||
[[Category: Zheng, A]] | [[Category: Zheng, A]] | ||
+ | [[Category: Zhou, T]] | ||
+ | [[Category: Antibody]] | ||
+ | [[Category: Hiv-1]] | ||
+ | [[Category: Immune system]] |
Revision as of 12:47, 3 June 2015
Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120
|
Categories: Kwong, P D | Moquin, S | Zheng, A | Zhou, T | Antibody | Hiv-1 | Immune system